| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |